Arabic Arabic English English French French German German
dark

FDA and CDC Virtual Press Conference: Johnson & Johnson COVID-19 Vaccine – 4/23/2021

Join us for a joint virtual press conference with the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration to discuss the Johnson & Johnson (Janssen) COVID-19 Vaccine.

Featuring:
• Janet Woodcock, M.D., Acting FDA Commissioner
• Rochelle Walensky, M.D., CDC Director
• Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research
• Anne Schuchat, M.D., CDC Principal Deputy Director

#COVID19

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Accolade Acquires Virtual Primary Care Platform PlushCare for $450M

Next Post

Obesity-associated inflammation: Does curcumin exert a beneficial role?

Related Posts

Panel Discussion

Sarah Ibrahim, Nilufer Tampal, Makini Cobourne-Duval, and Victoria Keck discuss audience questions. Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/generic-drugs-forum-2021-lifecycle-generic-drug-04282021-04292021 ——————–  FDA…
Read More
Total
0
Share